aimed analytics secures six-digit first funding and acquires ValueData GmbH
aimed analytics GmbH has successfully closed its first funding round, raising a six-digit investment. At the same time, the company has completed the acquisition of ValueData GmbH, further strengthening its position as a pioneer in AI-driven biomedical data analytics.
“Our mission is clear: to shape the future of medicine through the power of data analytics. The successful close of this round is a strong validation of our vision and our team’s work.”
Dr. Patrick Günther, CEO of aimed analytics
The investors of this round include proMetis Consulting GmbH, led by Dr. Guido Kemper, and Pi-Holding GmbH. Both partners contribute not only capital but also valuable expertise and strong networks to the company.
With the funding and the integration of ValueData GmbH, aimed analytics aims to accelerate the development of its self-service platform for omics data. The platform allows researchers to analyze complex datasets from genomics, transcriptomics, and epigenomics using natural language – enabling faster, clearer decision-making in drug discovery and biomedical research.
Beyond product development, aimed analytics will expand collaborations with partners in pharma and academia and strengthen its team.
